A crucial role for Gαq/11, but not Gαi/o or Gαs, in gonadotropin-releasing hormone receptor-mediated cell growth inhibition

Molecular Endocrinology

Volumn 22, Issue 11, 2008, Pages 2520-2530

  White, Colin D ^a   Coetsee, Marla ^a,c   Morgan, Kevin ^a   Flanagan, Colleen A ^b,c   Millar, Robert P ^a,c   Lu, Zhi Liang ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; GONADORELIN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 14; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; RECOMBINANT PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ARTICLE; BINDING ASSAY; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GROWTH INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL LINE; CELL PROLIFERATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE MUTANT; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CELL PROLIFERATION; CYCLIC AMP; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; RECEPTORS, LHRH; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 55049087495     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0122     Document Type: Article

References (72)

1. Millar RP, Lu ZL, Pawson AJ, Flanagan CA, Morgan K, Maudsley SR 2004 Gonadotropin-releasing hormone receptors. Endocr Rev 25:235-275
2. Emons G, Muller V, Ortmann O, Schulz KD 1998 Effects of LHRH-analogues on mitogenic signal transduction in cancer cells. J Steroid Biochem Mol Biol 65:199-206
3. Oikawa M, Dargan C, Ny T, Hsueh AJ 1990 Expression of gonadotropin-releasing hormone and prothymosin-α messenger ribonucleic acid in the ovary. Endocrinology 127:2350-2356
4. Palmon A, Ben Aroya N, Tel-Or S, Burstein Y, Fridkin M, Koch Y 1994 The gene for the neuropeptide gonadotropin-releasing hormone is expressed in the mammary gland of lactating rats. Proc Natl Acad Sci USA 91:4994-4996
5. Baumann KH, Kiesel L, Kaufmann M, Bastert G, Runnebaum B 1993 Characterization of binding sites for a GnRH-agonist (buserelin) in human breast cancer biopsies and their distribution in relation to tumor parameters. Breast Cancer Res Treat 25:37-46
6. Kakar SS, Grizzle WE, Neill JD 1994 The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary. Mol Cell Endocrinol 106:145-149
7. Mangia A, Tommasi S, Reshkin SJ, Simone G, Stea B, Schittulli F, Paradiso A 2002 Gonadotropin-releasing hormone receptor expression in primary breast cancer: comparison of immunohistochemical, radioligand and Western blot analyses. Oncol Rep 9:1127-1132
8. Irmer G, Burger C, Muller R, Ortmann O, Peter U, Kakar SS, Neill JD, Schulz KD, Emons G 1995 Expression of the messenger RNAs for luteinizing hormone-releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma. Cancer Res 55:817-822
9. Borri P, Coronnello M, Noci I, Pesciullesi A, Peri A, Caligiani R, Maggi M, Torricelli F, Scarselli G, Chieffi O, Mazzei T, Mini E 1998 Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues. Gynecol Oncol 71:396-403
10. Limonta P, Moretti RM, Marelli MM, Dondi D, Parenti M, Motta M 1999 The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: messenger ribonucleic acid expression, molecular size, and signal transduction pathway. Endocrinology 140:5250-5256
11. Klijn JG, de Jong FH 1982 Treatment with a luteinising hormone-releasing hormone analogue (buserelin) in pre-menopausal patients with metastatic breast cancer. Lancet 1:1213-1216
12. Dondi D, Limonta P, Moretti RM, Marelli MM, Garattini E, Motta M 1994 Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop. Cancer Res 54:4091-4095
13. Yano T, Pinski J, Radulovic S, Schally AV 1994 Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone. Proc Natl Acad Sci USA 91:1701-1705
14. Jeyarajah AR, Gallagher CJ, Blake PR, Oram DH, Dowsett M, Fisher C, Oliver RT 1996 Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancer. Gynecol Oncol 63:47-52
15. Dondi D, Moretti RM, Montagnani Marelli M, Pratesi G, Polizzi D, Milani M, Motta M, Limonta P 1998 Growth-inhibitory effects of luteinizing hormone-releasing hormone (LHRH) agonists on xenografts of the DU 145 human androgen-independent prostate cancer cell line in nude mice. Int J Cancer 76:506-511
16. 2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways. Cancer Res 64:5736-5744
17. i-coupling state of the type I GnRH receptor. Cancer Res 64:7533-7544
18. Gnanapragasam VJ, Darby S, Khan MM, Lock WG, Robson CN, Leung HY 2005 Evidence that prostate gonadotropin-releasing hormone receptors mediate an antitumourigenic response to analogue therapy in hormone refractory prostate cancer. J Pathol 206:205-213
19. White CD, Stewart AJ, Lu ZL, Millar RP, Morgan K 2008 Antiproliferative effects of GnRH agonists: prospects and problems for cancer therapy. Neuroendocrinology 88:67-79
20. Kimura A, Ohmichi M, Kurachi H, Ikegami H, Hayakawa J, Tasaka K, Kanda Y, Nishio Y, Jikihara H, Matsuura N, Murata Y 1999 Role of mitogen-activated protein kinase/extracellular signal-regulated kinase cascade in gonadotropin-releasing hormone-induced growth inhibition of a human ovarian cancer cell line. Cancer Res 59:5133-5142
21. Dobkin-Bekman M, Naidich M, Pawson AJ, Millar RP, Seger R, Naor Z 2006 Activation of mitogen-activated protein kinase (MAPK) by GnRH is cell-context dependent. Mol Cell Endocrinol 252:184-190
22. Levi NL, Hanoch T, Benard O, Rozenblat M, Harris D, Reiss N, Naor Z, Seger R 1998 Stimulation of jun-N-terminal kinase (JNK) by gonadotropin- releasing hormone in pituitary αT3-1 cell line is mediated by protein kinase C, c-Src and CDC42. Mol Endocrinol 12:815-824
23. Roberson MS, Zhang T, Li HL, Mulvaney JM 1999 Activation of the P38 mitogen-activated protein kinase pathway by gonadotropin-releasing hormone. Endocrinology 140:1310-1318
24. Naor Z, Benard O, Seger R 2000 Activation of MAPK cascades by G protein-coupled receptors: the case of gonadotropin-releasing hormone receptor. Trends Endocrinol Metab 11:91-99
25. Harris D, Bonfil D, Chuderland D, Kraus S, Seger R, Naor Z 2002 Activation of MAPK cascades by GnRH: ERK and jun-N-terminal kinase are involved in basal and GnRH-stimulated activity of the glycoprotein hormone LHβ-subunit promoter. Endocrinology 143:1018-1025
26. q/11 proteins. J Biol Chem 275:9193-9200
27. Imai A, Takagi H, Horibe S, Fuseya T, Tamaya T 1996 Coupling of gonadotropin-releasing hormone receptor to Gi protein in human reproductive tract tumors. J Clin Endocrinol Metab 81:3249-3253
28. i-mediated activation of phosphotyrosine phosphatase. Endocrinology 142:2369-2380
29. Grundker C, Gunthert AR, Westphalen S, Emons G 2002 Biology of the gonadotropin-releasing hormone system in gynecological cancers. Eur J Endocrinol 146:1-14
30. Limonta P, Moretti RM, Marelli MM, Motta M 2003 The biology of gonadotropin hormone-releasing hormone: role in the control of tumor growth and progression in humans. Front Neuroendocrinol 24:279-295
31. Kaiser UB, Conn PM, Chin WW 1997 Studies of gonadotropin-releasing hormone (GnRH) action using GnRH receptor-expressing pituitary cell lines. Endocr Rev 18:46-70
32. iα. Nature 363:274-276
33. Miller WR, Scott WN, Morris R, Fraser HM, Sharpe RM 1985 Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature 313:231-233
34. Millar RP, Pawson AJ, Morgan K, Rissman EF, Lu ZL 2008 Diversity of actions of GnRHs mediated by ligand-induced selective signaling. Front Neuroendocrinol 29:17-35
35. Kenakin T 2003 Ligand-selective receptor conformations revisited: the promise and the problem. Trends Pharmacol Sci 24:346-354
36. 11-mutant mice. EMBO J 17:4304-4312
37. 11α is not required for interaction with βγ complex. J Biol Chem 276:35883-35890
38. Sundaresan S, Colin IM, Pestell RG, Jameson JL 1996 Stimulation of mitogen-activated protein kinase by gonadotropin-releasing hormone: evidence for the involvement of protein kinase C. Endocrinology 137:304-311
39. Sim PJ, Wolbers WB, Mitchell R 1995 Activation of MAP kinase by the LHRH receptor through a dual mechanism involving protein kinase C and a pertussis toxin-sensitive G protein. Mol Cell Endocrinol 112:257-263
40. i-coupled receptors. Anal Biochem 270:242-248
41. 11α (pertussis toxin-insensitive) G proteins in αT3-1 gonadotroph cells reflects increased G protein turnover but not alterations in mRNA levels. Proc Natl Acad Sci USA 92:1886-1890
42. Delcourt N, Bockaert J, Marin P 2007 GPCR-jacking: from a new route in RTK signaling to a new concept in GPCR activation. Trends Pharmacol Sci 28:602-607
43. Krsmanovic LZ, Mores N, Navarro CE, Arora KK, Catt KJ 2003 An agonist-induced switch in G protein coupling of the gonadotropin-releasing hormone receptor regulates pulsatile neuropeptide secretion. Proc Natl Acad Sci USA 100:2969-2974
44. Janovick JA, Conn PM 1993 A cholera toxin-sensitive guanyl nucleotide binding protein mediates the movement of pituitary luteinizing hormone into a releasable pool: loss of this event is associated with the onset of homologous desensitization to gonadotropin-releasing hormone. Endocrinology 132:2131-2135
45. Starzec A, Jutisz M, Counis R 1989 Cyclic adenosine monophosphate and phorbol ester, like gonadotropin-releasing hormone, stimulate the biosynthesis of luteinizing hormone polypeptide chains in a nonadditive manner. Mol Endocrinol 3:618-624
46. Horton CD, Halvorson LM 2004 The cAMP signaling system regulates LHβ gene expression: roles of early growth response protein-1, SP1 and steroidogenic factor-1. J Mol Endocrinol 32:291-306
47. Stanislaus D, Ponder S, Ji TH, Conn PM 1998 Gonadotropin-releasing hormone receptor couples to multiple G proteins in rat gonadotrophs and in GGH3 cells: evidence from palmitoylation and overexpression of G proteins. Biol Reprod 59:579-586
48. s proteins in gonadotropin-releasing hormone receptor-mediated signaling in LβT2 cells. J Biol Chem 277:32099-32108
49. Lariviere S, Garrel G, Simon V, Soh JW, Laverriere JN, Counis R, Cohen-Tannoudji J 2007 Gonadotropin-releasing hormone couples to 3′,5′-cyclic adenosine-5′-monophosphate pathway through novel protein kinase Cδ and ε in LβT2 gonadotrope cells. Endocrinology 148:1099-1107
50. s-coupled receptor signaling pathways. J Biol Chem 277:21080-21085
51. Steiner D, Saya D, Schallmach E, Simonds WF, Vogel Z 2006 Adenylyl cyclase type-VIII activity is regulated by Gβγ subunits. Cell Signal 18:62-68
52. Feldman RD, Gros R 2007 New insights into the regulation of cAMP synthesis beyond GPCR/G protein activation: implications in cardiovascular regulation. Life Sci 81:267-271
53. Dhillon AS, Hagan S, Rath O, Kolch W 2007 MAP kinase signaling pathways in cancer. Oncogene 26:3279-3290
54. q-induced inhibition of cell proliferation. Biochem Biophys Res Commun 281:1019-1023
55. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH 2001 Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153-183
56. Raman M, Chen W, Cobb MH 2007 Differential regulation and properties of MAPKs. Oncogene 26:3100-3112
57. Kim KY, Choi KC, Auersperg N, Leung PC 2006 Mechanism of gonadotropin-releasing hormone (GnRH)-I and -II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway. Endocr Relat Cancer 13:211-220
58. Goulet AC, Chigbrow M, Frisk P, Nelson MA 2005 Selenomethionine induces sustained ERK phosphorylation leading to cell-cycle arrest in human colon cancer cells. Carcinogenesis 26:109-117
59. Koike K, Fujii T, Nakamura AM, Yokoyama G, Yamana H, Kuwano M, Shirouzu K 2006 Activation of protein kinase Cδ induces growth arrest in NPA thyroid cancer cells through extracellular signal-regulated kinase mitogen-activated protein kinase. Thyroid 16:333-341
60. Marshall CJ 1995 Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185
61. 1- to S-phase transition. Oncogene 26:3227-3239
62. Pumiglia KM, Decker SJ 1997 Cell-cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 94:448-452
63. Sewing A, Wiseman B, Lloyd AC, Land H 1997 High-intensity Raf signal causes cell-cycle arrest mediated by p21Cip1. Mol Cell Biol 17:5588-5597
64. Zhang H, Bailey JS, Coss D, Lin B, Tsutsumi R, Lawson MA, Mellon PL, Webster NJ 2006 Activin modulates the transcriptional response of LβT2 cells to gonadotropin-releasing hormone and alters cellular proliferation. Mol Endocrinol 20:2909-2930
65. Grundker C, Schlotawa L, Viereck V, Emons G 2001 Protein kinase C-independent stimulation of activator protein-1 and c-Jun-N-terminal kinase activity in human endometrial cancer cells by the LHRH agonist triptorelin. Eur J Endocrinol 145:651-658
66. Lu ZL, Gallagher R, Sellar R, Coetsee M, Millar RP 2005 Mutations remote from the human gonadotropin-releasing hormone (GnRH) receptor-binding sites specifically increase binding affinity for GnRH II but not GnRH I: evidence for ligand-selective, receptor-active conformations. J Biol Chem 280:29796-29803
67. Lu ZL, Coetsee M, White CD, Millar RP 2007 Structural determinants for ligand-receptor conformational selection in a peptide G protein-coupled receptor. J Biol Chem 282:17921-17929
68. Davidson L, Pawson AJ, Millar RP, Maudsley S 2004 Cytoskeletal reorganization dependence of signaling by the gonadotropin-releasing hormone receptor. J Biol Chem 279:1980-1993
69. Davidson L, Pawson AJ, de Maturana RL, Freestone SH, Barran P, Millar RP, Maudsley S 2004 Gonadotropin-releasing hormone-induced activation of diacylglycerol kinase ζ and its association with active c-Src. J Biol Chem 279:11906-11916
70. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
71. 35S]guanosine-5′-O-(3- thio)triphosphate binding mediated by cholinergic muscarinic receptors in membranes from Chinese hamster ovary cells and rat striatum using an anti-G protein scintillation proximity assay. J Pharmacol Exp Ther 289:946-955
72. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR 1990 New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107-1112